Winner

Alexion Pharmaceuticals Inc

Alexion Pharmaceuticals Inc Most Innovative Rare Disease Biopharmaceuticals Company 2017 & Best-in-Class Terminal Complement Inhibitor: Soliris®

International Life Sciences Awards - 2017